Prof. Dr. Thomas Harrer

Professur für Innere Medizin mit dem Schwerpunkt Immundefizienz

Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells. (2023) Bergmann C, Müller F, Distler J, Györfi AH, Völkl S, Aigner M, Kretschmann S, et al. Journal article, Letter Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections (2023) Schmitt C, Hoefsmit EP, Fangmeier T, Kramer N, Kabakci C, Vera González J, Versluis JM, et al. Journal article Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature (2023) Foerster Y, Sollfrank L, Rechtien L, Harrer T, Berking C, Sticherling M Journal article Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine (2023) Schmidt K, Harrer E, Schönau V, Simon D, Kleyer A, Steininger P, Korn K, et al. Journal article In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation (2023) Jensen BEO, Knops E, Cords L, Lübke N, Salgado M, Busman-Sahay K, Estes JD, et al. Journal article, Original article Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy (2022) Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Kremer A, Tenbusch M, et al. Conference contribution Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue (2022) Schlick S, Lucio M, Wallukat G, Bartsch A, Skornia A, Hoffmanns J, Szewczykowski C, et al. Journal article Core genome MLST for molecular typing of C. neoformans var. neoformans isolated in Germany (2004-2021) (2022) Wolf S, Helal M, Houtermann A, Smith IM, Gerkrath J, Koppe U, Stephan C, et al. Conference contribution Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation (2022) Szewczykowski C, Mardin C, Lucio M, Wallukat G, Hoffmanns J, Schröder T, Raith F, et al. Journal article PRE-EXPOSURE PROPHYLAXIS FOR SARS-COV-2 INFECTION WITH SUBCUTANEOUS CASIRIVIMAB/IMDEVIMAB IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES. (2022) Fagni F, Schmidt K, Bohr D, Valor L, Hartmann F, Tascilar K, Manger K, et al. Conference contribution